SCHEMBL15904202

SCHEMBL15904202

CCC(C)CN([C]=O)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4722760 0.73 MAPT (0.36)
SCHEMBL1401018 0.72
SCHEMBL276651 0.70
SCHEMBL269505 0.69
SCHEMBL1401104 0.69
SCHEMBL271193 0.67
Bicarbonate SCHEMBL13372634 0.66 FFAR3 (0.41)
Bicarbonate SCHEMBL14244821 0.66 FFAR3 (0.41)
Bicarbonate SCHEMBL9490653 0.66 FFAR3 (0.41)
Bicarbonate SCHEMBL14353233 0.66 FFAR3 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2948450-A1 METALLOENZYME INHIBITOR COMPOUNDS Viamet Pharmaceuticals, Inc. (US) 2015-12-02 EP disclosed
WO-2014117090-A1 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS, INC. (US) 2014-07-31 WO disclosed